Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-28

Clinical Trial Update: A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effects of liraglutide on gallbladder emptying in overweight and obese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 1 | Status: COMPLETED